Ironwood Pharmaceuticals IRWD Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's operating lease right-of-use assets in other assets?
- Ironwood Pharmaceuticals (IRWD) reported operating lease right-of-use assets in other assets of $8.9M in Q1 2026.
- How has Ironwood Pharmaceuticals's operating lease right-of-use assets in other assets changed year-over-year?
- Ironwood Pharmaceuticals's operating lease right-of-use assets in other assets decreased by 16.2% year-over-year, from $10.62M to $8.9M.
- What is the long-term trend for Ironwood Pharmaceuticals's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's operating lease right-of-use assets in other assets has grown at a -10.8% compound annual growth rate (CAGR), from $16.58M to $9.34M.